文献速递瓣膜外科

瓣膜再手术术后结局评估:一项回顾性研究

Evaluation of postoperative outcomes of valve reoperation: a retrospective study.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

基于日本心血管外科数据库2013至2015年54 269例瓣膜手术患者的回顾性分析,比较初次与再手术的术后结局。再手术组手术死亡率(9.1% vs 4.6%)和并发症发生率(41.4% vs 36.6%)均更高。倾向性评分匹配后,伴或不伴感染性心内膜炎患者的再手术死亡相对比值比分别为1.53和1.58。

要点

  • 再手术瓣膜手术死亡率和并发症率显著高于初次手术。
  • 再手术死亡危险因素包括急诊状态、EF<30%、感染性心内膜炎、透析等。
  • 初次手术时应考虑再手术风险,再手术指征需综合术前状态、时机和方式。

核心结论

  • 再手术瓣膜手术的术后结局显著劣于初次手术。
  • 初次手术时应考虑再手术风险,再手术指征需综合术前状态、手术时机和干预方式。

研究设计与样本

  • 回顾性分析日本心血管外科数据库2013至2015年54 269例瓣膜手术患者。
  • 分为初次手术组(n=49 833)和再手术组(n=4 436)。
  • 对再手术患者行多变量logistic回归分析危险因素,并按有无感染性心内膜炎行倾向性评分匹配比较初次与再手术结局。

主要发现

  • 再手术组术后死亡率9.1%高于初次组4.6%(P<0.001)。
  • 再手术组任何并发症发生率41.4%高于初次组36.6%(P<0.001)。
  • 再手术患者手术死亡强危险因素包括急诊状态、射血分数<30%、感染性心内膜炎、透析、慢性肾脏病、NYHA 3/4级、同期冠脉搭桥和主动脉手术、仅三尖瓣手术、多瓣膜手术和年龄。
  • 倾向性评分匹配队列中,伴感染性心内膜炎患者再手术死亡相对比值比1.53(95%CI 1.26-1.86,P<0.001)。
  • 不伴感染性心内膜炎患者再手术死亡相对比值比1.58(95%CI 1.18-2.13,P<0.002)。

临床怎么用

  • 瓣膜初次手术规划时应评估远期再手术风险。
  • 决定再手术指征时需综合考虑术前状态、手术时机和干预方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to compare the incidence of operative death and postoperative complications between primary and reoperation valve surgeries and to identify independent risk factors for these events among valve-reoperation patients. METHODS: Between 2013 and 2015, 54 269 patients who underwent valve surgery were retrospectively analyzed using the Japan Cardiovascular Surgery Database. They were divided into the primary (group P; n = 49 833) and reoperation (group R; n = 4436) surgery groups. Among the reoperation patients, we conducted multivariable logistic regression analyses to identify risk factors for the incidences of operative mortality and postoperative complications. Then, we also conducted propensity score matched analyses to compare the incidences of these 2 outcomes for primary versus reoperation procedures separately for patients with and without infective endocarditis (IE). RESULTS: Incidences of postoperative mortality (4.6% vs 9.1%; P < 0.001) and any complications (36.6% vs 41.4%; P < 0.001) were higher in the reoperation group. For patients undergoing reoperation, strong risk factors for operative mortality included urgency status, ejection fraction <30%, IE, dialysis, chronic kidney disease, New York Heart Association class 3/4, concomitant coronary artery bypass grafting and aorta procedure, tricuspid valve surgery only, multivalve surgery and age. In the propensity score matched cohort, the relative odds of operative mortality were 1.53 (95% confidence interval: 1.26-1.86, P < 0.001) among patients with IE and were 1.58 (95% confidence interval: 1.18-2.13, P < 0.002) among those without. CONCLUSIONS: Outcomes for reoperation were significantly worse than those for primary surgery. At the primary operation, the risk of reoperation should be considered and when considering the indications for reoperation, the preoperative state, surgical timing and intervention method should be considered.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Tatsuishi W, Kumamaru H, Nakano K, et al. Evaluation of postoperative outcomes of valve reoperation: a retrospective study. Eur J Cardiothorac Surg. 2021. PMID: 33221871. doi:10.1093/ejcts/ezaa384

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。